Bøger i Immunomics Reviews: serien

In contrast to existing books on immunoinformatics, this volume presents a cross-section of immunoinformatics research. Immunoinformatics is ideal for scientists and students in immunology, bioinformatics, microbiology, and many other disciplines.

This fourth volume of a series is dedicated to advances in immunomics. The focus is on systemic and integrative approaches in basic and clinical immunology, immunoinformatics, and immunologically relevant instrumentation and high-throughput screening methods.

This fourth volume of a series is dedicated to advances in immunomics. The focus is on systemic and integrative approaches in basic and clinical immunology, immunoinformatics, and immunologically relevant instrumentation and high-throughput screening methods.

In contrast to existing books on immunoinformatics, this volume presents a cross-section of immunoinformatics research. Immunoinformatics is ideal for scientists and students in immunology, bioinformatics, microbiology, and many other disciplines.

Although rapid progress has been made to identify the proteins playing pivotal roles in the innate immunity-related signalling pathways (for example, TIR signalling pathways), the catalogue of proteins with a key regulatory function identified and studied is far from completed.

By using genomic information we can study vaccine development in silico: 'reverse vaccinology', can identify candidate subunits vaccines by identifying antigenic proteins and by using equally rational approaches to identify novel immune response-enhancing adjuvants.

Although rapid progress has been made to identify the proteins playing pivotal roles in the innate immunity-related signalling pathways (for example, TIR signalling pathways), the catalogue of proteins with a key regulatory function identified and studied is far from completed.

By using genomic information we can study vaccine development in silico: 'reverse vaccinology', can identify candidate subunits vaccines by identifying antigenic proteins and by using equally rational approaches to identify novel immune response-enhancing adjuvants.